Updated:
Penn Medicine
Penn Medicine is a healthcare institution founded in 2001 in Philadelphia, Pennsylvania. It specializes in urology, providing treatment for various urologic...
Penn Medicine
Penn Medicine is a healthcare institution founded in 2001 in Philadelphia, Pennsylvania. It specializes in urology, providing treatment for various urologic conditions. The institution is staffed by a team of urology professionals.
General information
Firm type
Academic Health System
Year founded
1993
AUM
$5.1B annual research spend (per Penn Medicine, 2025)
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
Philadelphia, PA, United States
Additional offices
Shanghai, China
Principals
Dr. Kevin B. Mahoney
CEO, University of Pennsylvania Health System
Dr. J. Larry Jameson
Dean, Perelman School of Medicine
Sector focus
Frequently asked questions
Who leads investment decisions at Penn Medicine?
Investment decisions are not centralized under a single CIO; the University of Pennsylvania's endowment is managed by the Penn Investment Office, while clinical and research capital allocation is directed by CEO Kevin Mahoney and Dean Jameson. Technology transfer is run by the Penn Center for Innovation.
Does Penn Medicine act as a venture capital fund?
No. Penn Medicine operates as an academic medical center, not a fund. It does invest in its own spinouts through the Penn Center for Innovation, but does not manage a dedicated venture fund for external LPs. The institution's $10B+ endowment is invested by the University of Pennsylvania across public equities, private equity, and real assets.
How does Penn Medicine commercialize its research?
Through the Penn Center for Innovation, which handles patenting, licensing, and startup creation. Notable examples include Spark Therapeutics (acquired by Roche for $4.3B in 2019) and gene-editing tools licensed to companies like Editas Medicine. The institution shares revenue with inventors.
What is the relationship between Penn Medicine and the University of Pennsylvania's endowment?
The $10B+ endowment is managed by the separate Penn Investment Office. Penn Medicine does not directly allocate the endowment; its revenue comes from clinical care, grants, and philanthropy. The endowment supports the institution through payout distributions.
What investment stages does Penn Medicine typically target through its commercialization efforts?
Penn Medicine's tech transfer focuses on early-stage spinouts (pre-seed to Series A) in life sciences and devices. It also participates in federal grants (NIH SBIR/STTR) and collaborates with external VCs to fund later-stage trials.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: